CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

SB-216763 10mg  | ≥98%

CSNpharm

SB-216763 is potent and selective glycogen synthase kinase-3 (GSK-3) inhibitor (Ki = 9 nM) and competes with ATP.

More Information Supplier Page

SB-216763 5mg  | ≥98%

CSNpharm

SB-216763 is potent and selective glycogen synthase kinase-3 (GSK-3) inhibitor (Ki = 9 nM) and competes with ATP.

More Information Supplier Page

SB-216763 100mg  | ≥98%

CSNpharm

SB-216763 is potent and selective glycogen synthase kinase-3 (GSK-3) inhibitor (Ki = 9 nM) and competes with ATP.

More Information Supplier Page

SB-216763 50mg  | ≥98%

CSNpharm

SB-216763 is potent and selective glycogen synthase kinase-3 (GSK-3) inhibitor (Ki = 9 nM) and competes with ATP.

More Information Supplier Page

SB-216763 1mg  | ≥98%

CSNpharm

SB-216763 is potent and selective glycogen synthase kinase-3 (GSK-3) inhibitor (Ki = 9 nM) and competes with ATP.

More Information Supplier Page

SB-222200 50mg  | ≥98%

CSNpharm

SB-222200 is a selective, reversible and competitive antagonist of human NK-3 receptor (Ki=4.4 nM) that effectively crosses the blood-brain barrier.

More Information Supplier Page

SB-222200 1mg  | ≥98%

CSNpharm

SB-222200 is a selective, reversible and competitive antagonist of human NK-3 receptor (Ki=4.4 nM) that effectively crosses the blood-brain barrier.

More Information Supplier Page

SB-222200 5mg  | ≥98%

CSNpharm

SB-222200 is a selective, reversible and competitive antagonist of human NK-3 receptor (Ki=4.4 nM) that effectively crosses the blood-brain barrier.

More Information Supplier Page

SB-222200 10mg  | ≥98%

CSNpharm

SB-222200 is a selective, reversible and competitive antagonist of human NK-3 receptor (Ki=4.4 nM) that effectively crosses the blood-brain barrier.

More Information Supplier Page

SB-225002 10mg  | ≥99%

CSNpharm

SB225002 is a potent and selective non-peptide inhibitor of CXCR2 with IC50 of 22 nM, showing > 150-fold selectivity over CXCR1 and four other 7-TMRs.

More Information Supplier Page

SB-225002 100mg  | ≥99%

CSNpharm

SB225002 is a potent and selective non-peptide inhibitor of CXCR2 with IC50 of 22 nM, showing > 150-fold selectivity over CXCR1 and four other 7-TMRs.

More Information Supplier Page

SB-225002 25mg  | ≥99%

CSNpharm

SB225002 is a potent and selective non-peptide inhibitor of CXCR2 with IC50 of 22 nM, showing > 150-fold selectivity over CXCR1 and four other 7-TMRs.

More Information Supplier Page

SB-225002 250mg  | ≥99%

CSNpharm

SB225002 is a potent and selective non-peptide inhibitor of CXCR2 with IC50 of 22 nM, showing > 150-fold selectivity over CXCR1 and four other 7-TMRs.

More Information Supplier Page

SB-225002 5mg  | ≥99%

CSNpharm

SB225002 is a potent and selective non-peptide inhibitor of CXCR2 with IC50 of 22 nM, showing > 150-fold selectivity over CXCR1 and four other 7-TMRs.

More Information Supplier Page

SB-225002 50mg  | ≥99%

CSNpharm

SB225002 is a potent and selective non-peptide inhibitor of CXCR2 with IC50 of 22 nM, showing > 150-fold selectivity over CXCR1 and four other 7-TMRs.

More Information Supplier Page

SB-239063 1mg  | ≥99%

CSNpharm

SB 239063 is a potent, selective and oral active p38 MAPK inhibitor with IC50 of 44 nM for recombinant purified p38α.

More Information Supplier Page

SB-239063 10mg  | ≥99%

CSNpharm

SB 239063 is a potent, selective and oral active p38 MAPK inhibitor with IC50 of 44 nM for recombinant purified p38α.

More Information Supplier Page

SB-239063 5mg  | ≥99%

CSNpharm

SB 239063 is a potent, selective and oral active p38 MAPK inhibitor with IC50 of 44 nM for recombinant purified p38α.

More Information Supplier Page

SB-239063 50mg  | ≥99%

CSNpharm

SB 239063 is a potent, selective and oral active p38 MAPK inhibitor with IC50 of 44 nM for recombinant purified p38α.

More Information Supplier Page

SB-3CT 1mg  | ≥99%

CSNpharm

SB-3CT is a potent, competitive and non-selective MMP-2 and MMP-9 inhibitor with Ki values of 13.9 and 600 nM, respectively.

More Information Supplier Page

SB-3CT 10mg  | ≥99%

CSNpharm

SB-3CT is a potent, competitive and non-selective MMP-2 and MMP-9 inhibitor with Ki values of 13.9 and 600 nM, respectively.

More Information Supplier Page

SB-3CT 50mg  | ≥99%

CSNpharm

SB-3CT is a potent, competitive and non-selective MMP-2 and MMP-9 inhibitor with Ki values of 13.9 and 600 nM, respectively.

More Information Supplier Page

SB-3CT 5mg  | ≥99%

CSNpharm

SB-3CT is a potent, competitive and non-selective MMP-2 and MMP-9 inhibitor with Ki values of 13.9 and 600 nM, respectively.

More Information Supplier Page

SB-408124 5mg  | ≥98%

CSNpharm

SB-408124 is a non-peptide antagonist for OX1 receptor with Ki of 57 nM and 27 nM in both whole cell and membrane, respectively, and exhibits 50-fold selectivity over OX2 receptor.

More Information Supplier Page

SB-408124 10mg  | ≥98%

CSNpharm

SB-408124 is a non-peptide antagonist for OX1 receptor with Ki of 57 nM and 27 nM in both whole cell and membrane, respectively, and exhibits 50-fold selectivity over OX2 receptor.

More Information Supplier Page

SB-431542 5mg  | ≥99%

CSNpharm

SB-431542 is a potent and selective inhibitor of ALK5 with IC50 of 94 nM, 100-fold selective for ALK5 than p38 MAPK and other kinases.

More Information Supplier Page

SB-431542 100mg  | ≥99%

CSNpharm

SB-431542 is a potent and selective inhibitor of ALK5 with IC50 of 94 nM, 100-fold selective for ALK5 than p38 MAPK and other kinases.

More Information Supplier Page

SB-431542 10mg  | ≥99%

CSNpharm

SB-431542 is a potent and selective inhibitor of ALK5 with IC50 of 94 nM, 100-fold selective for ALK5 than p38 MAPK and other kinases.

More Information Supplier Page

SB-431542 50mg  | ≥99%

CSNpharm

SB-431542 is a potent and selective inhibitor of ALK5 with IC50 of 94 nM, 100-fold selective for ALK5 than p38 MAPK and other kinases.

More Information Supplier Page

SB-505124 50mg  | ≥99%

CSNpharm

SB505124 is an inhibitor of TGFβ receptor for ALK4 (IC50 = 129 nM) and ALK5 (IC50 = 47 nM). It can also inhibit ALK7.

More Information Supplier Page

SB-505124 10mg  | ≥99%

CSNpharm

SB505124 is an inhibitor of TGFβ receptor for ALK4 (IC50 = 129 nM) and ALK5 (IC50 = 47 nM). It can also inhibit ALK7.

More Information Supplier Page

SB-505124 1mg  | ≥99%

CSNpharm

SB505124 is an inhibitor of TGFβ receptor for ALK4 (IC50 = 129 nM) and ALK5 (IC50 = 47 nM). It can also inhibit ALK7.

More Information Supplier Page

SB-505124 5mg  | ≥99%

CSNpharm

SB505124 is an inhibitor of TGFβ receptor for ALK4 (IC50 = 129 nM) and ALK5 (IC50 = 47 nM). It can also inhibit ALK7.

More Information Supplier Page

SB-590885 10mg  | ≥98%

CSNpharm

SB-590885 is a potent B-Raf inhibitor with Ki of 0.16 nM, 11-fold greater selectivity for B-Raf over c-Raf, no inhibition to other human kinases.

More Information Supplier Page

SB-590885 5mg  | ≥98%

CSNpharm

SB-590885 is a potent B-Raf inhibitor with Ki of 0.16 nM, 11-fold greater selectivity for B-Raf over c-Raf, no inhibition to other human kinases.

More Information Supplier Page

SB-590885 50mg  | ≥98%

CSNpharm

SB-590885 is a potent B-Raf inhibitor with Ki of 0.16 nM, 11-fold greater selectivity for B-Raf over c-Raf, no inhibition to other human kinases.

More Information Supplier Page

SB-590885 100mg  | ≥98%

CSNpharm

SB-590885 is a potent B-Raf inhibitor with Ki of 0.16 nM, 11-fold greater selectivity for B-Raf over c-Raf, no inhibition to other human kinases.

More Information Supplier Page